Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Feb 24 | AKBA Akebia Therapeutics | Common Stock | Sell | Dispose S | No | No | 1.58 | 46,570 | 73.58 k | 2,044,580 |
27 Feb 24 | AKBA Akebia Therapeutics | Common Stock | Sell | Dispose S | No | No | 1.52 | 37,733 | 57.35 k | 2,091,150 |
1 Feb 24 | AKBA Akebia Therapeutics | Common Stock | Sell | Dispose S | No | No | 1.68 | 46,489 | 78.10 k | 2,128,883 |
31 Jan 24 | AKBA Akebia Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 603,500 | 0.00 | 2,175,372 |
31 Jan 24 | AKBA Akebia Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.68 | 905,200 | 1.52 mm | 905,200 |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Dispose U | No | No | 0 | 47,824 | 0.00 | 0 | |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Common Stock | Dispose U | No | No | 0 | 32,941 | 0.00 | 47,824 | |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.3501 | 71,736 | 25.11 k | 0 |
10 Oct 23 | ZYNE Zynerba Pharmaceuticals | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 1.01 | 34,663 | 35.01 k | 0 |